Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microbiome-based Stratification of Individuals at Risk of HIV-1 Acquisition, Chronic Clinical Complications, Antimicrobial Drug Resistance, and Unresponsiveness to Therapeutic HIV-1 Vaccination

NCT05421286 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT05421286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05421286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microbiome-based Stratification of Individuals at Risk of HIV-1 Acquisition, Chronic Clinical Complications, Antimicrobial Drug Resistance, and Unresponsiveness to Therapeutic HIV-1 Vaccination
Lead sponsor
Rigshospitalet, Denmark
Phase
Observational
Overall status
Active, not recruiting
Start date
September 28, 2022
Completion date
December 31, 2025
Enrollment
991 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

aids, hiv-1-infection, inflammation